HEADER MEMBRANE PROTEIN 17-APR-18 6GCI TITLE STRUCTURE OF THE BONGKREKIC ACID-INHIBITED MITOCHONDRIAL ADP/ATP TITLE 2 CARRIER COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOCHONDRIAL ADP/ATP CARRIER; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES; COMPND 6 OTHER_DETAILS: SEQUENCE HAS Q302K MUTATION; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: NANOBODY; COMPND 9 CHAIN: B; COMPND 10 ENGINEERED: YES; COMPND 11 OTHER_DETAILS: NANOBODY SELECTED AGAINST THE BKA-INHIBITED ADP/ATP COMPND 12 CARRIER SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: THERMOTHELOMYCES THERMOPHILA (STRAIN ATCC 42464 SOURCE 3 / BCRC 31852 / DSM 1799); SOURCE 4 ORGANISM_COMMON: SPOROTRICHUM THERMOPHILE; SOURCE 5 ORGANISM_TAXID: 573729; SOURCE 6 STRAIN: ATCC 42464 / BCRC 31852 / DSM 1799; SOURCE 7 ATCC: 42464; SOURCE 8 GENE: MYCTH_2316753; SOURCE 9 EXPRESSION_SYSTEM: SACCHAROMYCES CEREVISIAE; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 4932; SOURCE 11 EXPRESSION_SYSTEM_STRAIN: WB12; SOURCE 12 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 13 EXPRESSION_SYSTEM_PLASMID: PYES3; SOURCE 14 MOL_ID: 2; SOURCE 15 ORGANISM_SCIENTIFIC: LAMA GLAMA; SOURCE 16 ORGANISM_TAXID: 9844; SOURCE 17 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 18 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 19 EXPRESSION_SYSTEM_STRAIN: WK6; SOURCE 20 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 21 EXPRESSION_SYSTEM_PLASMID: PMESY4 KEYWDS TRANSPORTER, INHIBITOR, MITOCHONDRIAL, CARRIER, MEMBRANE PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR J.J.RUPRECHT,M.S.KING,E.PARDON,A.A.ALEKSANDROVA,T.ZOGG,P.G.CRICHTON, AUTHOR 2 J.STEYAERT,E.R.S.KUNJI REVDAT 4 17-JAN-24 6GCI 1 REMARK REVDAT 3 06-FEB-19 6GCI 1 JRNL REVDAT 2 16-JAN-19 6GCI 1 JRNL REVDAT 1 09-JAN-19 6GCI 0 JRNL AUTH J.J.RUPRECHT,M.S.KING,T.ZOGG,A.A.ALEKSANDROVA,E.PARDON, JRNL AUTH 2 P.G.CRICHTON,J.STEYAERT,E.R.S.KUNJI JRNL TITL THE MOLECULAR MECHANISM OF TRANSPORT BY THE MITOCHONDRIAL JRNL TITL 2 ADP/ATP CARRIER. JRNL REF CELL V. 176 435 2019 JRNL REFN ISSN 1097-4172 JRNL PMID 30611538 JRNL DOI 10.1016/J.CELL.2018.11.025 REMARK 2 REMARK 2 RESOLUTION. 3.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.3 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.35 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 85.1 REMARK 3 NUMBER OF REFLECTIONS : 13203 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.253 REMARK 3 R VALUE (WORKING SET) : 0.252 REMARK 3 FREE R VALUE : 0.283 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.760 REMARK 3 FREE R VALUE TEST SET COUNT : 628 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 7 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 3.30 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.57 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 44.80 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 1394 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2526 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1326 REMARK 3 BIN R VALUE (WORKING SET) : 0.2502 REMARK 3 BIN FREE R VALUE : 0.3013 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.88 REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3064 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 182 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 111.3 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 111.3 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.21070 REMARK 3 B22 (A**2) : 3.21070 REMARK 3 B33 (A**2) : -6.42130 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.550 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.484 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.487 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.869 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.889 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3303 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4454 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1501 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 561 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3303 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 414 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : 19 ; 1.000 ; HARMONIC REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3898 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.87 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.38 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 2.47 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -20.6005 29.8784 -8.8988 REMARK 3 T TENSOR REMARK 3 T11: 0.0992 T22: 0.1339 REMARK 3 T33: 0.0745 T12: -0.1450 REMARK 3 T13: 0.1179 T23: -0.0974 REMARK 3 L TENSOR REMARK 3 L11: 2.2605 L22: 3.8414 REMARK 3 L33: 4.5032 L12: 1.9950 REMARK 3 L13: -0.0631 L23: 0.2782 REMARK 3 S TENSOR REMARK 3 S11: -0.1776 S12: 0.1251 S13: 0.0523 REMARK 3 S21: -0.1159 S22: 0.0112 S23: -0.0320 REMARK 3 S31: 0.2613 S32: -0.0522 S33: 0.1664 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): -5.1570 34.9255 -50.1961 REMARK 3 T TENSOR REMARK 3 T11: -0.7065 T22: -0.0137 REMARK 3 T33: -0.9470 T12: -0.2816 REMARK 3 T13: 0.0500 T23: 0.2533 REMARK 3 L TENSOR REMARK 3 L11: 6.6519 L22: 5.6622 REMARK 3 L33: 16.0778 L12: 1.8189 REMARK 3 L13: -2.8537 L23: 2.3870 REMARK 3 S TENSOR REMARK 3 S11: 0.3457 S12: -0.0288 S13: 0.5294 REMARK 3 S21: -0.0425 S22: -0.2184 S23: -0.3114 REMARK 3 S31: -0.1338 S32: 2.1173 S33: -0.1273 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 (A) CRYSTAL DIFFRACTED ANISOTROPICALLY, AND DATA WAS TREATED WITH REMARK 3 STARANISO. REMARK 3 (B) FOURIER MAP COEFFICIENTS HAVE BEEN DEPOSITED ALONG WITH THE REMARK 3 OBSERVED DATA. REMARK 3 (C) A PEG MOLECULE LIES ON A SYMMETRY AXIS (SPECIAL POSITION) AND REMARK 3 HAS BEEN MODELLED WITH OCCUPANCY=0.5. REMARK 3 (D) SOME CARDIOLIPINS MOLECULES HAVE BEEN MODELLED WITH PARTIAL REMARK 3 OCCUPANCY, AS DESCRIBED IN THE ACCOMPANYING PAPER. REMARK 3 (E) MET250-SER252 AND LYS257 LIE IN VERY WEAK ELECTRON DENSITY. REMARK 3 THEIR POSITION IS SUPPORTED BY GOOD ELECTRON DENSITY OBTAINED FROM REMARK 3 AN EARLIER CRYSTAL. REMARK 3 (F) THERE ARE UNMODELLED BITS OF ELECTRON DENSITY NEAR THE N- REMARK 3 TERMINUS OF THE CARRIER, WHICH ARE LIKELY TO BE LIPID HEADGROUPS/ REMARK 3 TAILS. REMARK 3 (G) ADDITIONAL ELECTRON DENSITY AT THE C-TERMINUS OF THE CARRIER REMARK 3 INDICATES WHERE THE C-TERMINAL TAIL IS LIKELY TO RUN, BUT IT IS REMARK 3 NOT POSSIBLE TO MODEL THIS ACCURATELY. REMARK 3 (H) THE STRUCTURE FACTOR FILE CONTAINS A SECOND DATA BLOCK REMARK 3 CONTAINING THE STRUCTURE FACTORS FROM A CRYSTAL OF BKA-INHIBITED REMARK 3 TTAAC GROWN WITHOUT THE NANOBODY. THIS P212121 CRYSTAL DIFFRACTED REMARK 3 TO LOWER RESOLUTION AND WITH SIGNIFICANT ANISOTROPY, BUT WAS USED REMARK 3 TO CONFIRM THE DOMAIN POSITIONS OBSERVED IN THE P3221 CRYSTAL OF REMARK 3 THE TTAAC-NB COMPLEX. FULL DETAILS CAN BE FOUND IN THE PRIMARY REMARK 3 CITATION. REMARK 4 REMARK 4 6GCI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-APR-18. REMARK 100 THE DEPOSITION ID IS D_1200009733. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-AUG-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I24 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.96860 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AUTOPROC, AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13204 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.300 REMARK 200 RESOLUTION RANGE LOW (A) : 29.350 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 85.1 REMARK 200 DATA REDUNDANCY : 4.700 REMARK 200 R MERGE (I) : 0.06300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.43 REMARK 200 COMPLETENESS FOR SHELL (%) : 40.3 REMARK 200 DATA REDUNDANCY IN SHELL : 4.70 REMARK 200 R MERGE FOR SHELL (I) : 0.68800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5IMK, 4C9H REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 75.53 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 5.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M MES PH 6.5, 1% 3-METHYL-3 REMARK 280 -PENTANOL, 22% PEG400, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 283K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 196.98667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 98.49333 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 98.49333 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 196.98667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3850 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21550 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -17.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 O10 P6G B 301 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 ASN A 3 REMARK 465 LYS A 4 REMARK 465 GLN A 5 REMARK 465 GLU A 6 REMARK 465 THR A 7 REMARK 465 LYS A 8 REMARK 465 ILE A 9 REMARK 465 LEU A 10 REMARK 465 GLY A 253 REMARK 465 GLU A 254 REMARK 465 ALA A 255 REMARK 465 VAL A 256 REMARK 465 GLY A 307 REMARK 465 LYS A 308 REMARK 465 ALA A 309 REMARK 465 PHE A 310 REMARK 465 LYS A 311 REMARK 465 GLY A 312 REMARK 465 GLY A 313 REMARK 465 SER A 314 REMARK 465 GLY A 315 REMARK 465 ASP B 125 REMARK 465 ARG B 126 REMARK 465 ALA B 127 REMARK 465 ILE B 128 REMARK 465 GLU B 129 REMARK 465 GLY B 130 REMARK 465 ARG B 131 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET A 12 CG SD CE REMARK 470 GLU A 37 CG CD OE1 OE2 REMARK 470 LEU A 41 CG CD1 CD2 REMARK 470 GLU A 48 CG CD OE1 OE2 REMARK 470 ASP A 72 CG OD1 OD2 REMARK 470 GLU A 73 CG CD OE1 OE2 REMARK 470 MET A 76 CG SD CE REMARK 470 LYS A 110 CG CD CE NZ REMARK 470 LYS A 111 CG CD CE NZ REMARK 470 ASP A 112 CG OD1 OD2 REMARK 470 LYS A 113 CG CD CE NZ REMARK 470 LYS A 118 CG CD CE NZ REMARK 470 ASN A 164 CG OD1 ND2 REMARK 470 ARG A 171 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 172 CG CD CE NZ REMARK 470 ASN A 218 CG OD1 ND2 REMARK 470 LEU A 221 CG CD1 CD2 REMARK 470 MET A 250 CG SD CE REMARK 470 THR A 251 OG1 CG2 REMARK 470 SER A 252 OG REMARK 470 LYS A 257 CG CD CE NZ REMARK 470 LYS A 259 CG CD CE NZ REMARK 470 GLN A 267 CG CD OE1 NE2 REMARK 470 LYS A 271 CG CD CE NZ REMARK 470 LYS A 275 CG CD CE NZ REMARK 470 LYS A 279 CG CD CE NZ REMARK 470 ASN A 284 CG OD1 ND2 REMARK 470 ILE A 285 CG1 CG2 CD1 REMARK 470 GLN B 1 CG CD OE1 NE2 REMARK 470 GLN B 3 CG CD OE1 NE2 REMARK 470 GLN B 13 CG CD OE1 NE2 REMARK 470 ASP B 16 CG OD1 OD2 REMARK 470 GLU B 44 CG CD OE1 OE2 REMARK 470 ARG B 50 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 87 CG CD CE NZ REMARK 470 GLN B 106 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 45 46.29 -108.59 REMARK 500 TYR A 200 -73.00 -58.26 REMARK 500 SER A 260 145.99 68.79 REMARK 500 SER B 30 11.44 -69.15 REMARK 500 ILE B 48 -67.03 -90.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 CDL A 802 REMARK 610 CDL A 800 REMARK 610 CDL A 801 REMARK 610 CDL A 803 REMARK 610 CDL A 804 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue BKC A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CDL A 802 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CDL A 800 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CDL A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CDL A 803 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CDL A 804 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue P6G B 301 DBREF 6GCI A 1 315 UNP G2QNH0 G2QNH0_MYCTT 1 315 DBREF 6GCI B 1 131 PDB 6GCI 6GCI 1 131 SEQADV 6GCI LYS A 302 UNP G2QNH0 GLN 302 ENGINEERED MUTATION SEQRES 1 A 315 MET SER ASN LYS GLN GLU THR LYS ILE LEU GLY MET PRO SEQRES 2 A 315 PRO PHE VAL VAL ASP PHE LEU MET GLY GLY VAL SER ALA SEQRES 3 A 315 ALA VAL SER LYS THR ALA ALA ALA PRO ILE GLU ARG ILE SEQRES 4 A 315 LYS LEU LEU VAL GLN ASN GLN ASP GLU MET ILE LYS ALA SEQRES 5 A 315 GLY ARG LEU ASP ARG ARG TYR ASN GLY ILE ILE ASP CYS SEQRES 6 A 315 PHE ARG ARG THR THR ALA ASP GLU GLY LEU MET ALA LEU SEQRES 7 A 315 TRP ARG GLY ASN THR ALA ASN VAL ILE ARG TYR PHE PRO SEQRES 8 A 315 THR GLN ALA LEU ASN PHE ALA PHE ARG ASP LYS PHE LYS SEQRES 9 A 315 ALA MET PHE GLY TYR LYS LYS ASP LYS ASP GLY TYR ALA SEQRES 10 A 315 LYS TRP MET ALA GLY ASN LEU ALA SER GLY GLY ALA ALA SEQRES 11 A 315 GLY ALA THR SER LEU LEU PHE VAL TYR SER LEU ASP TYR SEQRES 12 A 315 ALA ARG THR ARG LEU ALA ASN ASP ALA LYS SER ALA LYS SEQRES 13 A 315 GLY GLY GLY ALA ARG GLN PHE ASN GLY LEU ILE ASP VAL SEQRES 14 A 315 TYR ARG LYS THR LEU ALA SER ASP GLY ILE ALA GLY LEU SEQRES 15 A 315 TYR ARG GLY PHE GLY PRO SER VAL ALA GLY ILE VAL VAL SEQRES 16 A 315 TYR ARG GLY LEU TYR PHE GLY MET TYR ASP SER ILE LYS SEQRES 17 A 315 PRO VAL VAL LEU VAL GLY PRO LEU ALA ASN ASN PHE LEU SEQRES 18 A 315 ALA SER PHE LEU LEU GLY TRP CYS VAL THR THR GLY ALA SEQRES 19 A 315 GLY ILE ALA SER TYR PRO LEU ASP THR VAL ARG ARG ARG SEQRES 20 A 315 MET MET MET THR SER GLY GLU ALA VAL LYS TYR LYS SER SEQRES 21 A 315 SER ILE ASP ALA PHE ARG GLN ILE ILE ALA LYS GLU GLY SEQRES 22 A 315 VAL LYS SER LEU PHE LYS GLY ALA GLY ALA ASN ILE LEU SEQRES 23 A 315 ARG GLY VAL ALA GLY ALA GLY VAL LEU SER ILE TYR ASP SEQRES 24 A 315 GLN LEU LYS ILE LEU LEU PHE GLY LYS ALA PHE LYS GLY SEQRES 25 A 315 GLY SER GLY SEQRES 1 B 131 GLN VAL GLN LEU VAL GLU SER GLY GLY GLY LEU VAL GLN SEQRES 2 B 131 ALA GLY ASP SER LEU ARG LEU ALA CYS ALA ALA SER GLY SEQRES 3 B 131 ILE THR PHE SER SER TYR THR MET GLY TRP PHE ARG GLN SEQRES 4 B 131 ALA PRO GLY LYS GLU ARG GLU TYR ILE ALA ARG ILE THR SEQRES 5 B 131 GLY SER GLY SER ASN THR TYR TYR ALA ASP SER VAL LYS SEQRES 6 B 131 GLY ARG TYR THR ILE SER ARG ASP ASN ALA LYS ASN THR SEQRES 7 B 131 ALA TYR LEU GLN MET ASN SER LEU LYS PRO GLU ASP THR SEQRES 8 B 131 ALA ASN TYR TYR CYS ALA ALA ARG ASP ASP GLY ARG MET SEQRES 9 B 131 TYR GLN GLY PHE TYR ASP PHE GLU TYR TRP GLY GLN GLY SEQRES 10 B 131 THR GLN VAL THR VAL SER SER ASP ARG ALA ILE GLU GLY SEQRES 11 B 131 ARG HET BKC A 401 35 HET CDL A 802 66 HET CDL A 800 21 HET CDL A 801 26 HET CDL A 803 9 HET CDL A 804 6 HET P6G B 301 19 HETNAM BKC BONGKREKIC ACID HETNAM CDL CARDIOLIPIN HETNAM P6G HEXAETHYLENE GLYCOL HETSYN BKC BONGKREK ACID HETSYN CDL DIPHOSPHATIDYL GLYCEROL; BIS-(1,2-DIACYL-SN-GLYCERO-3- HETSYN 2 CDL PHOSPHO)-1',3'-SN-GLYCEROL HETSYN P6G POLYETHYLENE GLYCOL PEG400 FORMUL 3 BKC C28 H38 O7 FORMUL 4 CDL 5(C81 H156 O17 P2 2-) FORMUL 9 P6G C12 H26 O7 HELIX 1 AA1 PRO A 13 ASN A 45 1 33 HELIX 2 AA2 GLN A 46 ALA A 52 1 7 HELIX 3 AA3 GLY A 61 GLY A 74 1 14 HELIX 4 AA4 LEU A 75 ARG A 80 5 6 HELIX 5 AA5 GLY A 81 GLY A 108 1 28 HELIX 6 AA6 LYS A 110 GLY A 115 1 6 HELIX 7 AA7 GLY A 115 GLY A 157 1 43 HELIX 8 AA8 GLY A 165 GLY A 178 1 14 HELIX 9 AA9 GLY A 178 TYR A 183 1 6 HELIX 10 AB1 GLY A 185 LEU A 212 1 28 HELIX 11 AB2 VAL A 213 ALA A 217 5 5 HELIX 12 AB3 PHE A 220 MET A 250 1 31 HELIX 13 AB4 SER A 260 GLU A 272 1 13 HELIX 14 AB5 GLY A 273 LYS A 279 1 7 HELIX 15 AB6 GLY A 280 ALA A 283 5 4 HELIX 16 AB7 ASN A 284 PHE A 306 1 23 HELIX 17 AB8 THR B 28 SER B 30 5 3 HELIX 18 AB9 LYS B 87 THR B 91 5 5 SHEET 1 AA1 4 GLN B 3 SER B 7 0 SHEET 2 AA1 4 LEU B 18 SER B 25 -1 O ALA B 23 N VAL B 5 SHEET 3 AA1 4 THR B 78 MET B 83 -1 O MET B 83 N LEU B 18 SHEET 4 AA1 4 TYR B 68 ASP B 73 -1 N ASP B 73 O THR B 78 SHEET 1 AA2 6 LEU B 11 GLN B 13 0 SHEET 2 AA2 6 THR B 118 SER B 123 1 O THR B 121 N VAL B 12 SHEET 3 AA2 6 ALA B 92 ASP B 100 -1 N TYR B 94 O THR B 118 SHEET 4 AA2 6 TYR B 32 GLN B 39 -1 N PHE B 37 O TYR B 95 SHEET 5 AA2 6 GLU B 46 ILE B 51 -1 O ALA B 49 N TRP B 36 SHEET 6 AA2 6 THR B 58 TYR B 60 -1 O TYR B 59 N ARG B 50 SHEET 1 AA3 4 LEU B 11 GLN B 13 0 SHEET 2 AA3 4 THR B 118 SER B 123 1 O THR B 121 N VAL B 12 SHEET 3 AA3 4 ALA B 92 ASP B 100 -1 N TYR B 94 O THR B 118 SHEET 4 AA3 4 TYR B 113 TRP B 114 -1 O TYR B 113 N ALA B 98 SSBOND 1 CYS B 22 CYS B 96 1555 1555 2.05 SITE 1 AC1 13 LYS A 30 ARG A 88 TYR A 89 THR A 92 SITE 2 AC1 13 GLN A 93 ASN A 96 LEU A 135 ILE A 193 SITE 3 AC1 13 TYR A 196 ARG A 197 TYR A 200 ARG A 287 SITE 4 AC1 13 GLY A 291 SITE 1 AC2 10 LEU A 136 TYR A 183 ARG A 184 GLY A 185 SITE 2 AC2 10 PHE A 186 GLY A 187 PRO A 188 TRP A 228 SITE 3 AC2 10 SER A 260 SER A 261 SITE 1 AC3 4 TRP A 79 GLY A 81 ASN A 82 THR A 83 SITE 1 AC4 6 PHE A 278 LYS A 279 GLY A 280 ALA A 281 SITE 2 AC4 6 GLY A 282 ALA A 283 SITE 1 AC5 3 GLY A 165 LEU A 166 ILE A 167 SITE 1 AC6 3 GLY A 61 ILE A 62 ILE A 63 SITE 1 AC7 5 ARG B 45 ASN B 93 TYR B 109 TRP B 114 SITE 2 AC7 5 GLN B 116 CRYST1 75.650 75.650 295.480 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013219 0.007632 0.000000 0.00000 SCALE2 0.000000 0.015264 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003384 0.00000